Both in Pharmaceuticals
CryoPort vs Arbutus Biopharma
Over the past year CYRX returned +92.1% and ABUS returned −13.0%; their daily moves had a correlation of 0.24.
CYRX +92.1% ABUS −13.0%Growth of $1, one year, split-adjusted
| Metric | CYRX | ABUS |
|---|---|---|
| Price | $17.29 | $4.21 |
| Market cap | $875.7M | $834.0M |
| Today | −5.47% | −1.64% |
| 1 month | −0.4% | −7.7% |
| 6 months | +67.1% | −2.5% |
| Year to date | +80.1% | −12.5% |
| 1 year | +87.1% | −8.7% |
| Revenue growth (YoY) | +7.7% | −90.6% |
| Gross margin | 46.6% | 100.0% |
| Net margin | −20.9% | −512.0% |
| P/E (TTM) | — | 5.5× |
| Price / sales | 4.7× | 4.6× |
| Net cash | $208.7M | $89.5M |
| Dividend yield | — | — |
| Volatility (60d) | 38.5% | 35.6% |
| Short % of float | 5.3% | 15.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).